Jefferies Financial Group provided analyst ratings for AstraZeneca stock on June 20, 2026.
6 reports, 3 independent
Updated Sep 2
Gone quiet
- Reports
- 6
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group provided analyst ratings for AstraZeneca stock on June 20, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies reissued a buy rating on AstraZeneca stock on August 16, 2026.1 source
Amundi increased its stake in AstraZeneca shares alongside Jefferies reaffirming a buy rating.1 source
Jefferies Financial Group issued analyst ratings for AstraZeneca.1 source
Keep exploring
The entities involved
-
Jefferies Financial Group
American financial services company
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- Jefferies Financial Group reissued a hold rating on June 18, 2026.
- Analyst rating updates reflect market sentiment involving Jefferies Financial Group and Zscaler.
- Citigroup reiterated a buy rating on ASM stock, while Jefferies cut its rating to strong sell.
- Jefferies Financial Group provided analyst ratings and price targets for Braemar Plc.
- Jefferies Financial Group reissued a buy rating for Dassault Aviation, while MarketBeat aggregated the stock data.